Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,070,224 | 1,100,954 | -47,317 | -156,430 | -116,121 |
| Depreciation Amortization | N/A | 1,851 | 841 | 3,748 | 2,885 |
| Accounts receivable | N/A | -22,366 | -621 | -7,099 | -8,600 |
| Accounts payable and accrued liabilities | N/A | -716 | -1,478 | 13,038 | -1,018 |
| Other Working Capital | -68,501 | -41,497 | -25,299 | 17,745 | -1,733 |
| Other Operating Activity | 184,483 | 181,392 | 3,213 | -5,969 | 13,986 |
| Operating Cash Flow | $1,186,206 | $1,219,618 | $-70,662 | $-134,968 | $-110,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -294,338 | -156,324 | 79,492 | -1,061,366 | -1,101,595 |
| PPE Investments | -2,587 | -1,959 | -911 | -1,458 | -1,309 |
| Purchase Sale Intangibles | -409 | -398 | -325 | -449 | -188 |
| Other Investing Activity | 3,291 | 3,196 | -325 | -449 | -189 |
| Investing Cash Flow | $-293,635 | $-155,087 | $78,257 | $-1,063,273 | $-1,103,092 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 53,631 | 54,518 |
| Common Stock Issued | 5,094 | 4,659 | 500 | 1,235,904 | 1,256,349 |
| Common Stock Repurchased | -63,763 | -50,559 | N/A | -51,016 | -51,860 |
| Other Financing Activity | -2,221 | -1,333 | -612 | -36,688 | -36,605 |
| Financing Cash Flow | $-60,889 | $-47,233 | $-112 | $1,201,831 | $1,222,402 |
| Exchange Rate Effect | -10,052 | -25,908 | -412 | 904 | 385 |
| Beginning Cash Position | 113,697 | 110,430 | 102,443 | 65,150 | 66,228 |
| End Cash Position | 935,327 | 1,101,820 | 109,515 | 69,644 | 75,324 |
| Net Cash Flow | $821,630 | $991,390 | $7,072 | $4,494 | $9,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,186,206 | 1,219,618 | -70,662 | -134,968 | -110,600 |
| Capital Expenditure | -2,587 | -1,959 | -911 | -1,458 | -1,309 |
| Free Cash Flow | 1,183,619 | 1,217,659 | -71,572 | -136,426 | -111,909 |